(Reuters Health) – Patients exiting clinical cancer trials may experience intense symptoms and emotions, as well as awareness of their impending mortality and the limited
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
